186 related articles for article (PubMed ID: 28630313)
1. Targeting reactive nitrogen species suppresses hereditary pancreatic cancer.
Li M; Chen Q; Ma T; Yu X
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):7106-7111. PubMed ID: 28630313
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic ductal adenocarcinoma in BRCA2 mutation carriers.
de Mestier L; Danset JB; Neuzillet C; Rebours V; Cros J; Soufir N; Hammel P
Endocr Relat Cancer; 2016 Oct; 23(10):T57-67. PubMed ID: 27511924
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of Brca2 promotes Trp53-associated but inhibits KrasG12D-dependent pancreatic cancer development in mice.
Rowley M; Ohashi A; Mondal G; Mills L; Yang L; Zhang L; Sundsbak R; Shapiro V; Muders MH; Smyrk T; Couch FJ
Gastroenterology; 2011 Apr; 140(4):1303-1313.e1-3. PubMed ID: 21199651
[TBL] [Abstract][Full Text] [Related]
4. BRCA2 and pancreatic cancer.
Naderi A; Couch FJ
Int J Gastrointest Cancer; 2002; 31(1-3):99-106. PubMed ID: 12622420
[TBL] [Abstract][Full Text] [Related]
5. Chromosome instability and carcinogenesis: insights from murine models of human pancreatic cancer associated with BRCA2 inactivation.
Cassidy LD; Liau SS; Venkitaraman AR
Mol Oncol; 2014 Mar; 8(2):161-8. PubMed ID: 24268522
[TBL] [Abstract][Full Text] [Related]
6. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
7. Assessing the Significance of BRCA1 and BRCA2 Mutations in Pancreatic Cancer.
Carnevale J; Ashworth A
J Clin Oncol; 2015 Oct; 33(28):3080-1. PubMed ID: 25987697
[No Abstract] [Full Text] [Related]
8. BRCA2 regulates homologous recombination in response to DNA damage: implications for genome stability and carcinogenesis.
Abaji C; Cousineau I; Belmaaza A
Cancer Res; 2005 May; 65(10):4117-25. PubMed ID: 15899802
[TBL] [Abstract][Full Text] [Related]
9. Familial pancreatic cancer asociated to germline mutation of BRCA2.
Sánchez Bermúdez AI; Marín Zafra G; Sarabia Meseguer MD
Med Clin (Barc); 2018 Apr; 150(8):e19-e20. PubMed ID: 29162271
[No Abstract] [Full Text] [Related]
10. Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.
Holter S; Borgida A; Dodd A; Grant R; Semotiuk K; Hedley D; Dhani N; Narod S; Akbari M; Moore M; Gallinger S
J Clin Oncol; 2015 Oct; 33(28):3124-9. PubMed ID: 25940717
[TBL] [Abstract][Full Text] [Related]
11. Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor.
Goehringer C; Sutter C; Kloor M; Gebert J; Slater EP; Keller M; Treiber I; Ganschow P; Kadmon M; Moog U
Fam Cancer; 2017 Apr; 16(2):303-309. PubMed ID: 27838800
[TBL] [Abstract][Full Text] [Related]
12. Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer.
Huang L; Wu C; Yu D; Wang C; Che X; Miao X; Zhai K; Chang J; Jiang G; Yang X; Cao G; Hu Z; Zhou Y; Zuo C; Wang C; Zhang X; Zhou Y; Yu X; Dai W; Li Z; Shen H; Liu L; Chen Y; Zhang S; Wang X; Liu Y; Sun M; Cao W; Gao J; Ma Y; Zheng X; Cheung ST; Jia Y; Tan W; Wu T; Lin D
Carcinogenesis; 2013 May; 34(5):1001-5. PubMed ID: 23299404
[TBL] [Abstract][Full Text] [Related]
13. Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2.
Wang H; Zeng ZC; Bui TA; DiBiase SJ; Qin W; Xia F; Powell SN; Iliakis G
Cancer Res; 2001 Jan; 61(1):270-7. PubMed ID: 11196174
[TBL] [Abstract][Full Text] [Related]
14. Lower level of BRCA2 protein in heterozygous mutation carriers is correlated with an increase in DNA double strand breaks and an impaired DSB repair.
Arnold K; Kim MK; Frerk K; Edler L; Savelyeva L; Schmezer P; Wiedemeyer R
Cancer Lett; 2006 Nov; 243(1):90-100. PubMed ID: 16448746
[TBL] [Abstract][Full Text] [Related]
15. Brca2 deficiency and Trp53 deregulation in pancreatic cancer: implications for therapeutic targeting.
Yee NS
Cancer Biol Ther; 2011 Jun; 11(11):969-73. PubMed ID: 21610317
[No Abstract] [Full Text] [Related]
16. Minding the gap: the underground functions of BRCA1 and BRCA2 at stalled replication forks.
Nagaraju G; Scully R
DNA Repair (Amst); 2007 Jul; 6(7):1018-31. PubMed ID: 17379580
[TBL] [Abstract][Full Text] [Related]
17. BRCA-associated pancreatico-biliary neoplasms: Four cases illustrating the emerging clinical impact of genotyping.
Sharma MB; Carus A; Sunde L; Hamilton-Dutoit S; Ladekarl M
Acta Oncol; 2016; 55(3):377-81. PubMed ID: 26004055
[No Abstract] [Full Text] [Related]
18. Identification of germline genetic mutations in patients with pancreatic cancer.
Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
[TBL] [Abstract][Full Text] [Related]
19. Systemic DNA damage accumulation under in vivo tumor growth can be inhibited by the antioxidant Tempol.
Georgakilas AG; Redon CE; Ferguson NF; Kryston TB; Parekh P; Dickey JS; Nakamura AJ; Mitchell JB; Bonner WM; Martin OA
Cancer Lett; 2014 Oct; 353(2):248-57. PubMed ID: 25069035
[TBL] [Abstract][Full Text] [Related]
20. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]